{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
ixazomib citrate
to a specific field?
Status:
Possibly Marketed Outside US
Source:
M020
(2024)
Source URL:
First approved in 2024
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M016
(2023)
Source URL:
First approved in 2021
Source:
M006
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M020
(2020)
Source URL:
First approved in 2020
Source:
M020
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M020
(2019)
Source URL:
First approved in 2016
Source:
DOUXO CALM MOUSSE by Ceva Sante Animale
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA076903
(2004)
Source URL:
First approved in 2004
Source:
ANDA076903
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2009)
Source URL:
First approved in 1955
Source:
Clorpactin WCS-90 by United-Guardian, Inc.
Source URL:
Class:
MIXTURE
Status:
Investigational
Source:
NCT03534063: Not Applicable Interventional Completed Pain, Postoperative
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03333824: Phase 1 Interventional Completed Solid Tumours
(2017)
Source URL:
Class:
PROTEIN
